Press Release

Everon Group appoints Milja Saksi as Group CEO

May 18, 2026

Turku, Finland, 18 May 2026

Everon Group is pleased to announce the appointment of Milja Saksi as its new Group CEO, effective 1 June 2026.

Milja Saksi brings over 20 years of experience in the healthcare and health tech industry, along with a strong track record of driving growth and transformation across Nordic companies.

Strong leadership for the next phase

As Everon enters its next phase, the company will continue to focus on strengthening its position in digital care solutions and supporting its customers in delivering high-quality care. Under Milja’s leadership, the company aims to continue its strong growth and strengthen its position in the current market in Sweden, the UK, and Finland.

“We are very pleased to welcome Milja Saksi to lead Everon into its next phase. Milja’s strong track record in driving growth and transformation, combined with her collaborative leadership style, makes her an excellent fit for Everon. We are confident that under her leadership, the company will continue to strengthen its market position and deliver long-term value for customers and stakeholders.”

— Mika Suomela, Chair of the Board, Everon Group

Acknowledgement of outgoing CEO Juha Sarsama

At the same time, Everon Group announces that current CEO Juha Sarsama will step down from his role at the end of May 2026.

During his tenure, Juha has played a key role in bringing together Everon’s country organisations into one unified group and establishing a strong foundation for future growth. Everon warmly thanks Juha for his dedication and leadership and wishes him all the best in his future endeavours.

“I am excited about this new possibility and look forward to working together with our dedicated people and customers to develop the whole industry further.”

— Milja Saksi

For further information, please contact:

Everon Group

Milja Saksi
milja.saksi@everon.se
+46 70 236 41 96

Mika Suomela, Chair of the Board, Everon Group
mika.suomela@versocapital.com
+358 50 483 4184

Related Articles

arrow-down